Skip to content
COP$139.06+2.12(+1.55%)ConocoPhillips Q3 profit beats on higher prices, hikes dividend7:26:13 AM ETMETA$636.99+6.99(+1.11%)UPDATE 2-Meta sells first bonds in euros, raises €9 billion7:25:25 AM ETDTE$138.25+3.99(+2.97%)UPDATE 1-DTE Energy to sell its non-utility business for about $3 billion7:23:30 AM ETAAPL$352.18+2.67(+0.76%)Jim Cramer's Surprise Midterm Winner: Apple, Because Fewer Data Centers Could Mean Cheaper Memory7:19:09 AM ETMU$763.30-32.16(-4.04%)Could Buying Micron Stock Today Help Set You Up for Life?7:17:00 AM ETMSFT$555.50-0.30(-0.05%)Microsoft Is Executing an Irreproducible Balance-Sheet-Backed Infrastructure Pre-Sale at Scale7:15:58 AM ETAAPL$352.18+2.67(+0.76%)Apple Vs. Tesla: Low CapEx Only Matters if Non-Cyclical Cash Flows Come With It7:15:57 AM ETIREN$20.98-0.72(-3.32%)IREN is Only Fit for a Specific Investor Currently7:15:22 AM ETCOP$139.06+2.12(+1.55%)BRIEF-Conocophillips Q3 Adjusted EPS USD 3.27 Vs. IBES Estimate USD 2.977:13:20 AM ETMU$763.30-32.16(-4.04%)Micron Just Closed Below $800 for the First Time Since July7:12:48 AM ETCOP$139.06+2.12(+1.55%)ConocoPhillips beats profit estimates, boosts quarterly dividend7:11:13 AM ETCRWD$234.12-6.88(-2.85%)Too Late to Buy CrowdStrike Stock? Here's the 1 Thing to Watch.7:10:00 AM ETGOOG$291.11+3.81(+1.33%)These 6 Stocks Make Up a Big Share of the S&P 5007:09:00 AM ETCOP$139.06+2.12(+1.55%)UPDATE 1-ConocoPhillips beats profit estimates, boosts quarterly dividend7:07:07 AM ETLLY$1,430.00+11.86(+0.84%)Iconic California Brand, French Florist, Celebrates Grand Opening of First Indiana Location7:07:00 AM ETCVS$81.00+1.01(+1.26%)ProjectLeo, the First Private AI Health Platform to Declare Independence From Big Tech7:04:00 AM ETCOP$139.06+2.12(+1.55%)ConocoPhillips beats quarterly profit estimates7:01:40 AM ETCOP$139.06+2.12(+1.55%)ConocoPhillips announces third-quarter 2026 results and increases quarterly ordinary dividend by 11%7:00:05 AM ETPG$168.66+1.34(+0.80%)P&G to Webcast Presentation From P&G Investor Day 2026, November 197:00:03 AM ETV$440.17+3.58(+0.82%)Visa Forecasts U.S. Holiday Spending to Rise 4.5% as Consumers Keep the Holidays a Priority7:00:00 AM ETHD$359.69+4.25(+1.20%)Transom Appoints David Shields as Executive Vice President, Operations and Finance7:00:00 AM ETGS$937.89+9.61(+1.04%)RPT-BREAKINGVIEWS-Hong Kong summit exposes Wall Street AI confusion7:00:00 AM ETDTE$138.25+3.99(+2.97%)DTE Energy to sell DTE Vantage business for about $3 billion6:59:28 AM ETACN$268.00+3.73(+1.41%)Mondelēz International and Accenture Transform Order-to-Cash With AI6:59:02 AM ET

ACB · NASDAQ

Aurora Cannabis Inc.

$5.17 -0.06 (-1.15%)

Company overview

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers, consumable vaporizer accessories, and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products, and the operation of CanvasRX, a network of cannabis counseling and outreach centers.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Market cap
$327M
Employees
1,073
Headquarters
Edmonton, AB
CEO
Miguel Martin
Listed
July 15, 2014
P/E
-3.06
Dividend yield
0.00%

Company financials

Revenue
$363M
Gross profit
$180M
Operating income
-$4.4M
EBITDA
$24.2M
Net income
-$42.5M
EPS
-$1.69
Total assets
$775M
Total debt
$101M
Gross margin
49.49%
Net margin
-11.71%
Earnings yield
-32.65%

Revenue segmentation

By product (FY 2026)

No product segmentation.

By region (FY 2026)

Showing FY 2026

Price chart

2.453.183.914.645.37
ACB 1D NASDAQ O5.16H5.26L5.10C5.23+0.07 (+1.36%)Vol2.94M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
View
Ticker Type Headline Source Published
ACBAurora Cannabis Inc. Press release Aurora Cannabis Announces Fiscal 2027 Second Quarter Results Business Wire
ACBAurora Cannabis Inc. Stock news CANADA RESEARCH ROUNDUP-Aurora Cannabis, Fortis, Toromont Industries Reuters
ACBAurora Cannabis Inc. Press release Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis PR Newswire
ACBAurora Cannabis Inc. Stock news BUZZ-Aurora Cannabis surges on Organigram's higher takeover offer Reuters
ACBAurora Cannabis Inc. Press release Organigram to Acquire Aurora and Establish a Global Cannabis Leader Business Wire
ACBAurora Cannabis Inc. Press release Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call Business Wire
ACBAurora Cannabis Inc. Stock news ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus Zacks Investment Research
ACBAurora Cannabis Inc. Press release Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program PRNewsWire
ACBAurora Cannabis Inc. Press release Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside Aurora Cannabis Inc. PR Newswire
ACBAurora Cannabis Inc. Stock news Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher The Motley Fool
ACBAurora Cannabis Inc. Stock news Comparing Aurora Cannabis (NASDAQ:ACB) & BeOne Medicines (NASDAQ:ONC) Defense World
ACBAurora Cannabis Inc. Press release Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output PRNewsWire
ACBAurora Cannabis Inc. Press release Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway PRNewsWire
ACBAurora Cannabis Inc. Stock news Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation MarketBeat
ACBAurora Cannabis Inc. Stock news Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid PRNewsWire
ACBAurora Cannabis Inc. Stock news Curaleaf raises Aurora Cannabis offer by 25% Proactive Investors
ACBAurora Cannabis Inc. Stock news Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch. The Motley Fool
ACBAurora Cannabis Inc. Press release Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure PR Newswire
ACBAurora Cannabis Inc. Press release Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond PR Newswire
ACBAurora Cannabis Inc. Stock news Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid MarketBeat
FAQ

Questions about Aurora Cannabis Inc.

What does Aurora Cannabis Inc. do?
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers, consumable vaporizer accessories, and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products, and the operation of CanvasRX, a network of cannabis counseling and outreach centers.
What is ACB's market cap?
Aurora Cannabis Inc. (ACB) is a listed stock with a live quote. The latest market cap on this page is $327M.
Where is Aurora Cannabis Inc. headquartered?
Aurora Cannabis Inc. is headquartered in Edmonton, AB.
How do I get ACB news from the API?
Call GET /v1/news?tickers=ACB. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does ACB news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for ACB, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the ACB price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.